Drug Approval | June 26, 2026
Merck wins EU nod for KEYTRUDA-Padcev regimen in muscle-invasive bladder cancer
The approval is based on results from the pivotal Phase 3 KEYNOTE-905 trial
The approval is based on results from the pivotal Phase 3 KEYNOTE-905 trial
Karkinos’ model aims to close both gaps by combining World Health Organization-recommended HPV DNA testing with a digitally enabled continuum of care
Biocon is actively advancing in the peptide field, having already secured regulatory approvals for certain critical molecules, with a clear focus on GLP-1 analogs and other peptides
The company plans to use this funding to boost AI capabilities, expand vernacular content ecosystem, accelerate product development, and scale user acquisition across Tier 2 and Tier 3 markets
His expertise spans supply chain management, strategic planning, operational transformation, and cross-functional leadership
The amendments notified under the Clinical Establishments Act, 2010 form part of this broader reform initiative aimed at creating a more responsive and facilitative regulatory ecosystem
Partnership with MAMTA HIMC aims to boost awareness, screening, HPV vaccination, and early detection of breast and cervical cancer in underserved communities
CDSCO-approved targeted therapy expands precision oncology options for patients with RET-driven lung, thyroid, and other advanced solid tumours
Innovative start-up award recognizes LIBERTY as a highly innovative, ground-breaking product with potentially wide range and/or substantial benefit
Partnership with Duopharma Biotech covers human insulin, insulin glargine and insulin aspart, supporting diabetes care and medicine security in Malaysia
Subscribe To Our Newsletter & Stay Updated
